Pyng Medical Corp.

Pyng Medical Corp.

March 19, 2007 09:01 ET

Pyng Medical Corp. Creates Global Customer Service and Distributor Support Capability

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - March 19, 2007) - As part of its on-going commitment to customer service and distributor support, Pyng Medical Corp. (TSX VENTURE:PYT) has hired Katherine Mitchell, BA as global Customer Service Representative. Katherine will be responsible for providing first class sales and service support to end-users and distributors. She brings with her a wealth of experience from a variety of industry sectors which encompassed both sales and customer service roles.

"The customer service role is a newly created position and reflects the continued growth within the company. Katherine will further enhance the service we offer our customers with support now available from 9 a.m. (EST) through to 5 p.m. (PST)," said David Christie, President and Chief Executive Officer of Pyng.

"It is very exciting to be a part of an organization that manufactures a life saving device. The best part of my role is helping people when they have a question. I enjoy the enthusiasm in their voices when talking about the FAST1™ Intraosseous Infusion System," said Katherine Mitchell.

About Pyng Medical Corp.

Pyng Medical Corp. is a world leader in intraosseous infusion with its proprietary award-winning FAST1™ Intraosseous Infusion System, the only device able to provide rapid sternal access and delivery of life saving fluids and drugs to the heart of critically injured patients within seconds. The FAST1™ is used extensively by the U.S. Department of Defense and by Emergency Medical Services around the globe.

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Pyng Medical Corp.
    David Christie
    (604) 303-7964